Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevention of menstrual migraine by percutaneous oestradiol.

Literature DB >> 3099950

Prevention of menstrual migraine by percutaneous oestradiol.

B de Lignières, M Vincens, P Mauvais-Jarvis, J L Mas, P J Touboul, M G Bousser.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Estradiol

Year: 1986 PMID： 3099950 PMCID： PMC1342315 DOI： 10.1136/bmj.293.6561.1540

Source DB: PubMed Journal: Br Med J (Clin Res Ed) ISSN： 0267-0623

× No keyword cloud information.

4 in total

1. Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration.

Authors: B W Somerville
Journal: Neurology Date: 1975-03 Impact factor: 9.910

2. Headache and sex hormone therapy.

Authors: L Dennerstein; B Laby; G D Burrows; G J Hyman
Journal: Headache Date: 1978-07 Impact factor: 5.887

3. Treatment of menstrual migraine by oestradiol implants.

Authors: A L Magos; K J Zilkha; J W Studd
Journal: J Neurol Neurosurg Psychiatry Date: 1983-11 Impact factor: 10.154

Review 4. Menstrual migraine and other hormonal aspects of migraine.

Authors: R N Edelson
Journal: Headache Date: 1985-10 Impact factor: 5.887

4 in total

24 in total

1. The pharmacological management of migraine, part 2: preventative therapy.

Authors: George Demaagd
Journal: P T Date: 2008-08

Review 2. Transdermal hormonal therapy in perimenstrual migraine: why, when and how?

Authors: Cristina Tassorelli; Rosaria Greco; Marta Allena; Erica Terreno; Rossella E Nappi
Journal: Curr Pain Headache Rep Date: 2012-10

Review 3. Migraine and the menopausal transition.

Authors: Vincent T Martin
Journal: Neurol Sci Date: 2014-05 Impact factor: 3.307

Review 4. Menstrual migraine.

Authors: Ana Recober; Lynne O Geweke
Journal: Curr Neurol Neurosci Rep Date: 2005-03 Impact factor: 5.081

5. Migraine in postmenopausal women and the risk of invasive breast cancer.

Authors: Robert W Mathes; Kathleen E Malone; Janet R Daling; Scott Davis; Sylvia M Lucas; Peggy L Porter; Christopher I Li
Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-11 Impact factor: 4.254

6. GABAA-receptor-mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges.

Authors: V Limmroth; W S Lee; M A Moskowitz
Journal: Br J Pharmacol Date: 1996-01 Impact factor: 8.739